Related Experiment Video
Updated: Aug 11, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Single-dose levodopa administration and aging independently disrupt time production
Brian C Rakitin1, Nikolaos Scarmeas, Tina Li
1Columbia University, New York, NY 10032, USA. br130@columbia.edu
Aging impairs time production, but this deficit is not dopamine-mediated. Levodopa lengthened time production in all participants, suggesting dopamine influences timing but not aging
Area of Science:
- Neuroscience
- Cognitive Psychology
- Human Aging Research
Background:
- Age-related cognitive decline often includes deficits in time perception.
- Dopamine is implicated in various cognitive functions, including timing and motor control.
Purpose of the Study:
- To investigate whether age-related deficits in time production are mediated by dopamine.
- To examine the effects of levodopa on time production in young and aged adults.
Main Methods:
- Double-blind, randomized controlled trial with 64 healthy participants (32 young, 32 aged).
- Participants received either levodopa (200 mg) or placebo.
- Time production of 6 and 17-second intervals was assessed before and after drug administration, with a 1-hour delay.
- A reaction time task was used to control for attention and psychomotor speed.
Main Results:
- Aged participants exhibited larger timing errors than young participants, particularly for longer intervals.
- Levodopa administration increased time production for both target intervals in all participants.
- Aging slowed reaction time and increased its variability, but levodopa did not affect reaction time.
- No interaction was found between aging and levodopa effects on time production.
Conclusions:
- Time production appears to be dopamine-mediated, as levodopa influenced timing.
- The age-related deficit in time production is not dopamine-mediated under these experimental conditions.
- The observed levodopa effect on timing is independent of its effects on psychomotor speed.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
